Please provide your email address to receive an email when new articles are posted on . The tacrolimus group had a 1.86-fold higher rate of relapse-free survival vs. those assigned mycophenolate ...
Tacrolimus prolongs relapse-free survival in pediatric patients with steroid-dependent or frequently relapsing nephrotic syndrome. Tacrolimus significantly extends relapse-free survival compared with ...
In paediatric kidney transplant recipients, high variability in tacrolimus trough blood levels was significantly associated with allograft rejection occurring beyond 12 months post-transplant; however ...
The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
A new study out of Japan explored the long-term safety and efficacy of tacrolimus, an immunosuppressive drug that blocks T-cell activation and suppresses autoantibody production, in people with lupus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results